| Date | Subject |
| 05/02/2012 11:11:47 AM | |
| Hepatitis C Drug Can Cause Depression |
| 04/26/2012 02:59:36 PM | |
| FDA: Co-Administration of Boceprevir With Certain Boosted HIV Protease Inhibitors Not Recommended |
| 04/25/2012 04:23:08 PM | |
| Reduction of Tacrolimus Possible With Early Introduction of Everolimus After Liver Transplant: Presented at EASL |
| 04/25/2012 03:51:47 PM | |
| Interferon-Free Combination Regimen Shows Promise for the Treatment of Chronic HCV: Presented at EASL |
| 04/25/2012 03:22:59 PM | |
| Non-Interferon-Based Combination Therapy Offers High Response Rates for Hepatitis C Patients: Presented at EASL |
| 04/25/2012 12:53:01 PM | |
| Short-Term Aramchol Reduces Liver Fat Content Safely in Patients With NAFLD and NASH: Presented at EASL |
| 04/25/2012 11:58:10 AM | |
| Boceprevir Improves Rates of Sustained Virological Response in HCV/HIV Coinfected Patients: Presented at EASL |
| 04/25/2012 11:55:25 AM | |
| Novel Uridine Nucleotide Analogue Safe, Effective for Patients With HCV Receiving Pegylated Interferon/Ribavirin: Presented at EASL |
| 04/25/2012 11:09:01 AM | |
| Eltrombopag Increases Platelet Counts During HCV Treatment in Patients With Thrombocytopenia: Presented at EASL |
| 04/25/2012 11:06:24 AM | |
| Delaying Treatment in New Cases of Hepatitis C Infection Considered Unnecessary: Presented at EASL |
| 04/24/2012 06:15:50 PM | |
| Daclatasvir Plus PSI-7977 Provides Significant Response in Treatment of HCV Across Genotypes: Presented at EASL |
| 04/24/2012 06:06:04 PM | |
| Brivanib Improves Time-to-Progression in Patients With HCC, but Fails to Improve Overall Survival: Presented at EASL |
| 04/24/2012 03:02:56 PM | |
| Family History of Liver Cancer Increases Risk of Developing Hepatocellular Carcinomas |
| 04/24/2012 03:00:27 PM | |
| Boceprevir Helps Prior Nonresponders With HCV Genotype 1 to Achieve SVR: Presented at EASL |
| 04/24/2012 02:57:47 PM | |
| TMC435 Combined With PEG IFN alfa-2a/RBV Is Well Tolerated and Significantly More Effective Than PEG IFN alfa-2a/RBV Alone in HCV Genotype 1: Presented at EASL |
| 04/24/2012 02:53:14 PM | |
| Fibrosis and Fatty Liver Disease Increase Risk of Early Atherosclerosis |
| 04/24/2012 01:22:33 PM | |
| Alisporivir in Hepatitis C Genotype 1 Warrants Further Study, but Research on Hold: Presented at EASL |
| 04/24/2012 12:42:15 PM | |
| PEG IFN Lambda-1a Provides Improved Efficacy and Safety Over IFN Alpha for Treating Hepatitis C: Presented at EASL |
| 04/23/2012 12:31:54 PM | |
| Ultrasound May Not Be Adequate for Liver Cancer Screening in Patients Coinfected With HIV, Hepatitis: Presented at BHIVA |
| 04/19/2012 12:13:54 PM | |
| New Clinical Practice Guideline on Alcoholic Liver Disease Published |
| 04/03/2012 03:52:35 PM | |
| New Biomarker to Identify Patients With HBV At-Risk for Liver Cancer |
| 04/03/2012 01:33:28 PM | |
| Anidulafungin Shows Efficacy in Liver Disease-Related Fungal Infections: Presented at ECCMID |
| 03/23/2012 12:04:17 PM | |
| Study Identifies Genetic Variants Linked to Fatty Liver Disease in Obese Children |
| 03/15/2012 03:22:50 PM | |
| EASL and EORTC Publish Joint Guidelines on Hepatocellular Carcinoma Management |
| 03/08/2012 12:01:23 PM | |
| Boceprevir Added to PEG-IFN Plus Ribavirin Effective for Treating HIV Patients Coinfected With Hepatitis C Virus: Presented at CROI |
| 03/08/2012 11:58:41 AM | |
| Telaprevir Combined With PEG-IFN alfa-2a Plus Ribavirin Benefits Patients Coinfected With Hepatitis C and HIV: Presented at CROI |
| 03/06/2012 12:53:11 PM | |
| Bevacizumab May Be a Therapeutic Option for Hereditary Haemorrhagic Telangiectasia |
| 03/05/2012 03:00:34 PM | |
| Gadoxetic Acid-Enhanced MRI Yields Superior Results in Assessing Patients With Suspected Liver Metastases: Presented at ECR |
| 03/01/2012 03:46:18 PM | |
| FDA Issues Recommendations Concerning Drug-Drug Interactions Between PIs, Statins |
| 03/01/2012 12:35:18 PM | |
| Cyclosporine Induces Higher Sustained Viral Response Rates After Liver Transplant for HCV: Presented at CDDW |
| 02/29/2012 12:51:48 PM | |
| Transient Elastography Accurate for Detecting Sever Fibrosis Due to Recurrent HCV |
| 02/09/2012 11:55:13 AM | |
| Concomitant Use of Boceprevir, Ritonavir-Boosted PIs Can Decrease Efficacy of Both Drugs |
| 02/07/2012 03:52:22 PM | |
| EASL Publishes First European Clinical Practice Guidelines for Wilson’s Disease |
| 02/07/2012 03:37:28 PM | |
| Patients With Cirrhosis, Low Muscle Mass Have a Higher Death Rate |
| 02/06/2012 06:25:31 PM | |
| Three Targeted Cancer Drugs Raise Risk of Fatal Side Effects |
| 02/02/2012 03:19:28 PM | |
| Rituximab Shows Promise for Patients With Primary Biliary Cirrhosis |
| 02/01/2012 04:29:22 PM | |
| Many Paediatric Liver Transplant Recipients Can Safely Stop Immunosuppressive Therapy |
| 02/01/2012 02:54:01 PM | |
| 2012 Adult Immunization Schedule Broadens Recommendations for HPV, HBV Vaccinations |
| 02/01/2012 02:49:07 PM | |
| Type of Anaesthesia May Affect Recurrence Risk After Liver Cancer Procedure |
| 01/31/2012 04:29:41 PM | |
| Cardiopulmonary Exercise Testing May Predict Survival After Liver Transplantation |
| 01/26/2012 03:22:11 PM | |
| Live Liver Donation Safer Than Previously Thought |
| 01/19/2012 12:05:36 PM | |
| Combination of Oral Antiviral Agents Can Help Suppress Hepatitis C Virus |
| 01/18/2012 04:20:45 PM | |
| Novel Gene Mutations Associated With Bile Duct Cancer |
| 01/17/2012 03:15:56 PM | |
| Immunosuppression Withdrawal May Be Feasible for Paediatric Liver Transplant Recipients |
| 01/10/2012 12:34:05 PM | |
| New Fibrosis Classification Improves Accuracy of Diagnosis in Hepatitis C |
| 01/10/2012 12:20:08 PM | |
| High Rates of Disability Observed Among Older Patients With Cirrhosis |
| 01/04/2012 03:06:48 PM | |
| Maternal Liver Grafts More Tolerable for Children With Biliary Atresia |
| 12/16/2011 01:19:40 PM | |
| Deferasirox Reduces Iron Overload in Beta-Thalassaemia Patients not Requiring Transfusions: Presented at ASH |
| 12/14/2011 04:28:27 PM | |
| Obesity and Diabetes Epidemics Spur Increase in Nonalcoholic Steatohepatitis |
| 12/02/2011 06:40:27 PM | |
| CT and MRI Similar in Detecting Liver Cancer Among Patients With Cirrhosis: Presented at RSNA |
| 12/02/2011 04:17:16 PM | |
| Ultrasound Surveillance of Liver Cancer Appears to Find Most Lesions at Early Stages: Presented at RSNA |
| 12/02/2011 09:38:57 AM | |
| Adherence to Liver Cancer Screening Guidelines for Patients With HCV Appears Low: Presented at RSNA |
| 12/01/2011 04:11:49 PM | |
| Studies of Patients With Cirrhosis Uncover Limitations in Liver Cancer Screening |
| 12/01/2011 12:24:43 PM | |
| Dual-Energy CT With Spectral Imaging Differentiates Neoplastic From Bland Portal Vein Thrombi: Presented at RSNA |
| 11/25/2011 02:41:51 PM | |
| Researchers Surprised to Find Fatty Liver Disease Poses No Excess Risk for Death |
| 11/11/2011 06:56:14 PM | |
| Replacing Calcineurin Inhibitor With Everolimus Safe With Better Renal Function: Presented at AASLD |
| 11/11/2011 06:42:11 PM | |
| Superiority of Terlipressin Plus Albumin for Hepatorenal Syndrome: Presented at AASLD |
| 11/11/2011 04:23:58 PM | |
| No Hepatitis B Virus Resistance to Tenofovir Seen Out to 5 Years: Presented at AASLD |
| 11/11/2011 11:55:26 AM | |
| Poxvirus Shows Promising Activity Against Hepatocellular Carcinoma: Presented at AASLD |
| 11/11/2011 11:48:39 AM | |
| Eltrombopag Adjunct Therapy Improves HCV Response in Cirrhotic Patients: Presented at AASLD |
| 11/09/2011 04:59:22 PM | |
| Miravirsen Shows Promise Against HCV in First Clinical Trial: Presented at AASLD |
| 11/09/2011 04:55:25 PM | |
| Radiofrequency Ablation, Surgical Resection Equally Effective for Early-Stage Hepatocellular Carcinoma: Presented at AASLD |
| 11/09/2011 04:30:08 PM | |
| Antenatal Lamivudine May Be Deferred to Third Trimester for High-Risk Mothers With HBV: Presented at AASLD |
| 11/09/2011 03:18:40 PM | |
| Telaprevir Improves Treatment of Patients Coinfected With HIV and Hepatitis C Receiving Efavirenz: Presented at AASLD |
| 11/08/2011 04:25:51 PM | |
| Once-Daily Agent Offers 100% SVR Rates Against HCV Genotype 2 or 3: Presented at AASLD |
| 11/08/2011 04:17:17 PM | |
| Danoprevir Helps Treatment-Naïve Patients With HCV Achieve Sustained Virologic Response: Presented at AASLD |
| 11/08/2011 03:45:35 PM | |
| Alisporivir Offers Early Viral Clearance in Half of Patients With Hepatitis C Virus Genotype 2 or 3: Presented at AASLD |
| 11/08/2011 02:45:25 PM | |
| Treatment-Naïve Patients With HCV Achieve Rapid Virological Response With Novel PI, Standard Care: Presented at AASLD |
| 11/08/2011 12:29:35 PM | |
| Telaprevir Improves Response Rates in Patients With Hepatitis C Virus Genotype 1 and Cirrhosis: Presented at AASLD |
| 11/08/2011 12:24:02 PM | |
| Enoxaparin Prevents Portal-Vein Thrombosis, Reduces Decompensation in Advanced Cirrhosis: Presented at AASLD |
| 11/07/2011 05:28:35 PM | |
| Investigational Protease Inhibitor Boosts Sustained Virologic Response in Patients With Hepatitis C Virus Genotype 1: Presented at AASLD |
| 11/07/2011 01:11:43 PM | |
| Black Patients With Hepatitis C Increase Their Sustained Response With Boceprevir: Presented at AASLD |
| 11/07/2011 12:43:38 PM | |
| Utility and Safety for Prolonged Treatment of Chronic Hepatitis B in Children: Presented at AASLD |
| 11/01/2011 03:54:50 PM | |
| Recipients of Organ Transplants at Increased Risk for Broad Range of Cancers |
| 10/26/2011 11:45:26 AM | |
| R0 Resection Remains Goal in Colorectal Liver Metastases: Presented at ACS |
| 10/18/2011 03:28:34 PM | |
| New Strategy Facilitates HCV Screening Among HIV-Positive Individuals |
| 10/17/2011 04:57:52 PM | |
| Largest Ever Genetic Study of Liver Function Could Point the Way to New Treatments |
| 10/05/2011 03:35:22 PM | |
| Excess BMI in Childhood Associated With an Increased Risk of Liver Cancer in Adulthood |
| 09/27/2011 03:51:20 PM | |
| Living Donor Liver Transplantation Improves Survival Over Deceased Donor Transplants |
| 09/27/2011 02:50:35 PM | |
| Regorafenib Safe for Patients With Hepatocellular Cancer Who Have Progressed on Sorafenib: Presented at ECCO-ESMO |
| 09/22/2011 12:30:17 PM | |
| European Medicines Agency Recommends Restricting Use of Dronedarone |
| 09/20/2011 11:56:07 AM | |
| Telaprevir Approved in Europe for Genotype-1 Chronic Hepatitis C Virus |
| 09/15/2011 12:24:09 PM | |
| Shorter Course of Hepatitis C Treatment as Effective as 48-Week Regimen |
| 09/13/2011 05:40:26 PM | |
| Substituting Brand Name Tacrolimus With Generic Form is Safe for Transplant Recipients |
| 09/09/2011 04:33:39 PM | |
| Day 7 Bilirubin Levels Predict Early Graft Survival in Paediatric Liver Transplant Recipients: Presented at ESOT |
| 09/09/2011 03:46:40 PM | |
| Major Postoperative Liver Transplant Complications Associated With Hepatitis Reinfection: Presented at ESOT |
| 09/09/2011 03:39:04 PM | |
| Xerostomia, Burning Mouth Syndrome Common Among Liver Transplant Recipients: Presented at ESOT |
| 08/22/2011 01:26:15 PM | |
| Radioembolisation Improves Chance of Survival for Patients With Liver Cancer |
| 08/22/2011 11:38:04 AM | |
| Health Canada Approves Telaprevir for Patients With Hepatitis C |
| 08/09/2011 04:33:42 PM | |
| New Non-Invasive Technology Shows Promise for Hepatocellular Carcinoma |
| 08/03/2011 11:39:00 AM | |
| Health Canada Approves Boceprevir for the Treatment of Chronic HCV |
| 07/27/2011 05:25:04 PM | |
| Study: Viral Hepatitis Rates Forecast a Liver Health Crisis |
| 07/26/2011 02:42:29 PM | |
| Single-Dose H1N1 Vaccine Not Reliable Protection for Paediatric Liver-Transplant Patients |
| 07/21/2011 04:22:07 PM | |
| Metabolic Syndrome Increases Risk of Primary Liver Cancers |
| 07/21/2011 03:59:58 PM | |
| Hepatitis C Virus is Transmitted by Unprotected Sex Between HIV+ Men |
| 07/21/2011 03:57:53 PM | |
| Study Suggests Obesity Accelerates Progression of Cirrhosis |
| 07/18/2011 01:26:51 PM | |
| European Commission Approves Boceprevir for Chronic Hepatitis C |
| 06/28/2011 03:37:55 PM | |
| Gene Variant Increases Fatty Liver Risk, Fibrosis Progression |
| 06/27/2011 02:56:24 PM | |
| Stepped-Up Vaccine Series for Hepatitis B Effective During Pregnancy |
| 06/23/2011 05:52:55 PM | |
| Telaprevir-Based Regimen Improves HCV Cure Rates |
| 06/22/2011 05:31:01 PM | |
